Yes, targeting aggregation is a promising approach for cancer therapy. Researchers are exploring ways to disrupt cell-cell interactions and the extracellular matrix to prevent or reduce aggregation. For instance, inhibiting specific cell adhesion molecules or signaling pathways involved in aggregation could potentially hinder tumor growth and metastasis. Additionally, novel therapeutic strategies aim to enhance the delivery and efficacy of chemotherapeutic agents by overcoming the barriers created by aggregated cells.
